NM_001318510.2(ACSL4):c.181C>G (p.Leu61Val) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: May 4, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003442343.1

Allele description [Variation Report for NM_001318510.2(ACSL4):c.181C>G (p.Leu61Val)]

NM_001318510.2(ACSL4):c.181C>G (p.Leu61Val)

Gene:

ACSL4:acyl-CoA synthetase long chain family member 4 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

Xq23

Genomic location:

Preferred name:

NM_001318510.2(ACSL4):c.181C>G (p.Leu61Val)

HGVS:

NC_000023.11:g.109683183G>C
NG_008053.1:g.55210C>G
NM_001318509.2:c.304C>G
NM_001318510.2:c.181C>GMANE SELECT
NM_004458.3:c.181C>G
NM_022977.3:c.304C>G
NP_001305438.1:p.Leu102Val
NP_001305439.1:p.Leu61Val
NP_004449.1:p.Leu61Val
NP_075266.1:p.Leu102Val
NC_000023.10:g.108926412G>C
NM_004458.2:c.181C>G

Protein change:

L102V

Molecular consequence:

NM_001318509.2:c.304C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001318510.2:c.181C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_004458.3:c.181C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_022977.3:c.304C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004169876	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Uncertain significance (May 4, 2023)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004169876

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Uncertain significance
(May 4, 2023)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV004169876.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 25, 2023

ClinVar

Relating variation to medicine